A 16-year Remained UroLume Stent without any Complication; a Case Report
Urology Journal,
Vol. 19 No. 02 (2022),
5 May 2022
,
Page 157-158
https://doi.org/10.22037/uj.v19i02.6874
Abstract
Lumen diameter reduction which is called urethral stricture has several causative agents including iatrogenic,
inflammatory, traumatic, and idiopathic factors. The main treatment options are transurethral or open surgical interventions.The UroLume which was introduced around 33 years ago is an intraurethral stent and as a temporary treatment approach has a maximum 9-month durability, but here we present the first ever reported forgotten 16-year remained UroLume without any complication.
- Urethral Stricture
- Stents
- Prostatic Hyperplasia
How to Cite
References
Mangir N, Chapple C. Recent Advances in treatment of urethral stricture disease in men. F1000Research. 2020;9.
Abdeen BM, Badreldin AM. Urethral Strictures. StatPearls [Internet]. 2020.
Alwaal A, Blaschko S, McAninch J, Breyer B. Epidemiology of urethral strictures. Transl Androl Urol 2014; 3: 209–13.
Tritschler S, Roosen A, Füllhase C, Stief CG, Rübben H. Urethral stricture: etiology, investigation and treatments. Deutsches Ärzteblatt International. 2013;110:220.
Frankiewicz M, Karolina M, Marcin M. Diagnosis and Management of Urolume Urethral Stent Complications Using Ultrasonography and Magnetic Resonance Imaging. Urology. 2020;144:e4-e5.
Botelho F, Thomas AA, Miocinovic R, Angermeier KW. Endoscopic removal of a proximal urethral stent using a holmium laser: Case report and literature review. Urology annals. 2012;4:191.
CORUJO M, BADLANI GH. Uncommon complications of permanent stents. Journal of endourology. 1998;12:385-8.
McNamara ER, Webster GD, Peterson AC. The UroLume stent revisited: the Duke experience. Urology. 2013;82:933-6.
Feagure Legeand:
Figure 1: RUG of a 53-year old man with a 16-year remained UroLume and without any stricture
- Abstract Viewed: 301 times
- 6874/pdf Downloaded: 202 times